Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion type Assertion NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_head.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion description "[The enrichment of ERBB2 mutations/fusion in CDH1-mutated ILC (5 of 22, 23%) compared with the 5 ERBB2 mutations in a series of 286 non-CDH1-mutated breast cancers from which the ILC cases were obtained (5 of 286, 2%) was significant (P = 0.0006).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_provenance.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion evidence source_evidence_literature NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_provenance.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion SIO_000772 23575477 NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_provenance.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion wasDerivedFrom befree-2016 NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_provenance.
- NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_assertion wasGeneratedBy ECO_0000203 NP1068230.RAlCixP7a0Ov8Ogsnxu3EWZqubfXFyvk0AqcZ9Lwwv78I130_provenance.